Russia readies for approval of second Covid-19 vaccine - official
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Wednesday
February 01, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
WEDNESDAY, FEBRUARY 01, 2023
Russia readies for approval of second Covid-19 vaccine - official

Coronavirus chronicle

Reuters
26 August, 2020, 09:50 pm
Last modified: 26 August, 2020, 09:52 pm

Related News

  • Syria receives first shipment of Russian shots - report
  • Young Pakistanis rush to purchase Russian vaccine as private sales open
  • Africa proves rocky terrain for Russian and Chinese vaccines
  • EU says no talks under way to buy Russia's Covid-19 vaccine
  • EU regulator says Russia yet to submit Covid-19 vaccine application

Russia readies for approval of second Covid-19 vaccine - official

Speaking at a televised government meeting, Golikova told President Vladimir Putin that early-stage clinical trials on the vaccine, developed by the Vector virology institute in Siberia, would be completed by the end of September

Reuters
26 August, 2020, 09:50 pm
Last modified: 26 August, 2020, 09:52 pm
FILE PHOTO: A handout photo shows vials during the production of "Gam-Covid-Vac" vaccine against the coronavirus disease (Covid-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), at Binnopharm pharmaceutical company in Zelenograd near Moscow, Russia August 7, 2020. The Russian Direct Investment Fund (RDIF)/Andrey Rudakov/Handout via REUTERS
FILE PHOTO: A handout photo shows vials during the production of "Gam-Covid-Vac" vaccine against the coronavirus disease (Covid-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), at Binnopharm pharmaceutical company in Zelenograd near Moscow, Russia August 7, 2020. The Russian Direct Investment Fund (RDIF)/Andrey Rudakov/Handout via REUTERS

Russia is preparing to approve a second vaccine against COVID-19 in late September or early October, Russian Deputy Prime Minister Tatiana Golikova said on Wednesday.

Speaking at a televised government meeting, Golikova told President Vladimir Putin that early-stage clinical trials on the vaccine, developed by the Vector virology institute in Siberia, would be completed by the end of September.

"As of today there have been no complications among those vaccinated in the first and second stages of testing," she said.

Earlier this month Russia became the first country to grant regulatory approval to a Covid-19 vaccine after less than two months of human testing.

The approved vaccine, called "Sputnik V" in homage to the world's first satellite launched by the Soviet Union, has been hailed as safe and effective by Russian authorities. But Western experts have been sceptical about Russia's approval of "Sputnik V", warning against its use until all internationally approved testing and regulatory steps have been taken.

RDIF, Russia's sovereign wealth fund, said on Wednesday the final phase of clinical trials on "Sputnik V" were beginning.

It said 40,000 people would take part in the final trials and that similar trials would also be carried out in five other countries.

Sergei Sobyanin, the mayor of Moscow, said residents of the Russian capital could apply to take part in the trials.

These final trials, carried out on a large number of people, are normally considered essential precursors for a vaccine to receive regulatory approval.

Russian Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Bloomberg
    Adani rout passes $80 billion as stock sale fails to stems doubt
  • Mugging rife in Tejgaon, murder in Wari
    Mugging rife in Tejgaon, murder in Wari
  • Will reform pledges to IMF work this time?
    Will reform pledges to IMF work this time?

MOST VIEWED

  • People walk outside wearing masks during the coronavirus disease (COVID-19) pandemic in the Harlem area of the Manhattan borough of New York City, New York, U.S., February 10, 2022. REUTERS/Carlo Allegri
    US to end Covid-19 emergency declarations on 11 May
  • A nurse prepares a shot for Jonathan Halter as the German embassy begins its roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas Peter/File Photo
    Covid remains a public health emergency, says WHO
  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs
  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot

Related News

  • Syria receives first shipment of Russian shots - report
  • Young Pakistanis rush to purchase Russian vaccine as private sales open
  • Africa proves rocky terrain for Russian and Chinese vaccines
  • EU says no talks under way to buy Russia's Covid-19 vaccine
  • EU regulator says Russia yet to submit Covid-19 vaccine application

Features

An elderly couple's lonely battle to save Dhaka's trees

An elderly couple's lonely battle to save Dhaka's trees

5h | Panorama
Infographic: TBS

How to redirect inward remittances to formal channels

7h | Panorama
Photo: Bloomberg

How the 'madoffs of Manhattan' can unravel Gautam Adani's empire

6h | Panorama
Photo: Collected

Tips to incorporate sustainable construction

1d | Habitat

More Videos from TBS

Alka Yagnik guinness world record

Alka Yagnik guinness world record

4h | TBS Entertainment
Interest rate should be left to market

Interest rate should be left to market

4h | TBS Round Table
Adani’s shares fell sharply after allegation

Adani’s shares fell sharply after allegation

20h | TBS World
Why Messi was blocked on Instagram?

Why Messi was blocked on Instagram?

19h | TBS SPORTS

Most Read

1
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

2
Photo: Collected
Energy

8 Ctg power plants out of production

3
Photo: Saqlain Rizve
Bangladesh

Bangladeshi university students identified as problematic users of Facebook, internet: Study

4
Photo: Collected
Court

Japanese mother gets guardianship of daughters, free to leave country

5
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

6
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]